Managing Alerts and Adverse Events Remotely in Decentralized Clinical Trials
In a DCT setting, alerts and AEs can originate from various digital sources:
Click to read the full article.
In a DCT setting, alerts and AEs can originate from various digital sources:
Click to read the full article.
Participants must be fully informed about what data is being collected, how it will be used, who will have access, and how long it will be retained. Recommendations include:
Click to read the full article.
Training should empower staff to integrate with centralized monitoring plans. This includes recognizing data trends, correlating remote vitals with patient outcomes, and participating in cross-functional virtual meetings for faster decision-making. These practices also support broader goals of stability studies in pharmaceuticals by maintaining consistent data oversight.
Click to read the full article.
Overview: Verily, a subsidiary of Alphabet Inc., launched Project Baseline, an extensive research platform that includes the Heart Health Study.
Click to read the full article.
Many modern trials are adopting hybrid models, where site visits are conducted for critical time points while the rest of the study utilizes remote follow-up.
Click to read the full article.
Telemedicine is the use of digital communication technologies to conduct virtual medical visits. In DCTs, it enables:
Click to read the full article.
Telehealth platforms are secure digital tools that enable two-way video/audio consultations between patients and healthcare professionals. In the context of clinical trials, they help conduct:
Click to read the full article.
In traditional trials, informed consent is obtained in person. In DCTs, teleconsultation provides the flexibility to:
Click to read the full article.
Decentralized models shift trial operations from brick-and-mortar sites to patients’ homes. Virtual visits help:
Click to read the full article.
Before conducting the telehealth interaction, ensure the following:
Click to read the full article.
